Provista Diagnostics Expands Exclusive License Agreement for Biomarker Technologies Developed at the Biodesign Institute at Arizona State University

Provista Diagnostics, Inc., a molecular diagnostics company developing and commercializing proteomic-based diagnostic, prognostic and monitoring tests for cancers affecting women, announced it has expanded its exclusive license agreement for certain biomarker and autoantibody technologies identified by researchers Joshua LaBaer, M.D., Ph.D. and Karen Anderson, M.D., Ph.D. of the Biodesign Institute of Arizona State University.  The license provides Provista with access to patents, proprietary technology, materials, processing techniques and protocols necessary for detection of certain autoantibodies and use of certain biomarkers. Continue reading

Moving Up

In January 2013 at TEDx Beacon Street, Harvard Business School’s Rosabeth Moss Kanter  shared Six Keys to Leading Positive Change.  Let’s look at how can we apply them to grow our Bioscience and Healthcare Industry here in Arizona so we can individually and collectively keep things moving up.Continue reading

Yulex CEO Jeff Martin Named Ernst & Young Entrepreneur Of The Year Finalist

Jeff Martin, co-founder and CEO of Yulex, has been named a finalist for the Ernst & Young (EY) Entrepreneur Of The Year 2014 Award in the Mountain Desert region. The awards program recognizes entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities.Continue reading